Rongfeng Fu
Overview
Explore the profile of Rongfeng Fu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
278
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kirito K, Qin A, Suo S, Fu R, Wu D, Sato T, et al.
BJC Rep
. 2024 Nov;
2(1):51.
PMID: 39516248
No abstract available.
2.
Fu R, Dong H, Gu W, Meng K, Sun T, Liu X, et al.
Leukemia
. 2024 Oct;
39(1):155-165.
PMID: 39375514
The paucity of essential thrombocythemia (ET) and prefibrotic primary myelofibrosis (pre-PMF) in individuals younger than 18 years highlights several unresolved issues in diagnosis, clinical outcomes, and treatment strategies. To address...
3.
Yu D, Xue F, Liu X, Chen Y, Fu R, Sun T, et al.
Res Pract Thromb Haemost
. 2024 Sep;
8(6):102554.
PMID: 39346578
Background: Isolated acquired clotting factor deficiencies (ACFDs) are mainly caused by the existence of anti-factor antibodies or adsorption of clotting factors onto substances such as amyloid. Besides acquired factor (F)VIII...
4.
Dong H, Chen J, Zhang J, Xue F, Li H, Zhang D, et al.
Clin Cancer Res
. 2024 Sep;
30(23):5473-5482.
PMID: 39330983
Purpose: Triple-negative (TN) essential thrombocytopenia (ET) is characterized by the absence of driver mutations while retaining histologic and phenotypic characteristics sufficient for an ET diagnosis. Our understanding of TN-ET and...
5.
Wen Q, Sun T, Chen J, Li Y, Liu X, Li H, et al.
Br J Haematol
. 2024 Sep;
205(5):1938-1950.
PMID: 39253817
Primary immune thrombocytopenia (ITP) is an autoimmune bleeding disorder, and chemokines have been shown to be dysregulated in autoimmune disorders. We conducted a prospective analysis to identify potential chemokines that...
6.
Zhang A, Sun T, Yu D, Fu R, Liu X, Xue F, et al.
Clin Exp Med
. 2024 Jul;
24(1):154.
PMID: 38972952
Essential thrombocythemia (ET) and prefibrotic primary myelofibrosis (pre-PMF) are Philadelphia chromosome-negative myeloproliferative neoplasms. These conditions share overlapping clinical presentations; however, their prognoses differ significantly. Current morphological diagnostic methods lack reliability...
7.
Chen Y, Xu Y, Li H, Sun T, Cao X, Wang Y, et al.
N Engl J Med
. 2024 Jun;
390(23):2178-2190.
PMID: 38899695
Background: Immune thrombocytopenia (ITP) is an autoimmune disease characterized by autoantibody-mediated platelet destruction. Treatment with CM313, a novel anti-CD38 monoclonal antibody, can result in targeted clearance of CD38-positive cells, including...
8.
Chen Y, Xu Y, Chi Y, Sun T, Gao Y, Dou X, et al.
Signal Transduct Target Ther
. 2024 Apr;
9(1):102.
PMID: 38653983
Patients with refractory immune thrombocytopenia (ITP) frequently encounter substantial bleeding risks and demonstrate limited responsiveness to existing therapies. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) present a promising alternative, capitalizing on...
9.
Chen J, Dong H, Li Y, Sun T, Fu R, Liu X, et al.
Chin Med J (Engl)
. 2024 Apr;
137(12):1495-1497.
PMID: 38616661
No abstract available.
10.
Qu X, Xue F, Liu W, Chen Y, Ju M, Sun T, et al.
Br J Haematol
. 2024 Apr;
205(1):347-351.
PMID: 38590024
No abstract available.